Practice
Featured experience
Nordson $800 million acquisition of Atrion
We are advising Nordson on the acquisition
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Owens Corning $3.9 billion acquisition of Masonite International
We are advising Owens Corning on the acquisition
Equinix $2 billion at-the-market offering
We advised Equinix on the offering
Mirion Technologies $150 million registered direct offering
We advised Mirion on the offering
Truist $1.95 billion sale of a stake in Truist Insurance to Stone Point Capital
We are advising Truist as the seller on this transaction
CureVac $250 million follow-on offering
We advised CureVac on the equity offering
Xponential Fitness $122.5 million secondary offering
We advised Xponential Fitness on the offering
Comcast $1 billion inaugural green bond offering
We advised Comcast on the investment-grade debt offering
ADC Therapeutics secondary offering
We advised ADC Therapeutics on the registered secondary offering of its shares
Roivant Sciences $230 million stock offering
We advised the company on its SEC-registered offering
Precigen $75 million follow-on offering
We advised Precigen on the SEC-registered offering
Morgan Stanley $2 billion subordinated reset notes offering
We advised Morgan Stanley on its SEC-registered global offering
Morgan Stanley $4 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering